Open AccessAssessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland
Author(s) -
Albert J. Augustin,
Matthias Becker,
Katja Hatz,
Hakan Kaymak,
Andrew Shirlaw
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s315548
Subject(s) - medicine , diabetic macular edema , macular edema , dexamethasone , ophthalmology , diabetic retinopathy , visual acuity , confidence interval , adverse effect , edema , retinal , retrospective cohort study , diabetes mellitus , surgery , endocrinology
The purpose was to assess the number and intervals of dexamethasone intravitreal implant (DEX) reinjections in a real-world setting for the treatment of diabetic macular edema (DME) and to determine the relationship with effectiveness and safety.